In human alloreactive CD4+ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets

被引:14
|
作者
Eleftheriadis, Theodoros [1 ]
Sounidaki, Maria [1 ]
Pissas, Georgios [1 ]
Antoniadi, Georgia [1 ]
Liakopoulos, Vassilios [1 ]
Stefanidis, Ioannis [1 ]
机构
[1] Univ Thessaly, Sch Med, Dept Nephrol, Mezourlo Hill, Larisa 41110, Greece
关键词
alloreactivity; dichloroacetate; T-cell; glycolysis; Th1; Th2; Th17; Treg; INDOLEAMINE 2,3-DIOXYGENASE; RENAL-TRANSPLANTATION; SUBPOPULATIONS; METABOLISM; ACTIVATION; INDUCTION; TOLERANCE;
D O I
10.3892/mmr.2016.4912
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although kidney transplantation is the best therapy for end-stage renal disease, rejection remains a concern, and currently available immunosuppressive agents contribute to morbidity and mortality. Thus, novel immunosuppressive drugs are required. Dichloroacetate (DCA) is already used in the treatment of congenital lactic acidosis and characterized by limited toxicity. As DCA inhibits aerobic glycolysis, which is a prerequisite for CD4(+) T-cell proliferation and differentiation into effector T-cells, its possible immunosuppressive role in mixed lymphocyte reaction (MLR), a model of alloreactivity, was investigated. Glucose and lactate concentrations were measured in the supernatants, and cell proliferation was assessed immunoenzymatically. CD4(+) T-cells were then isolated from the MLRs and the expression of cleaved caspase-3, various enzymes involved in glycolysis, and the signature transcription factors of CD4(+) T-cell subsets were evaluated by western blotting. In MLRs, DCA decreased glucose consumption and aerobic glycolysis, while it exerted a negligible effect on cell proliferation. In CD4(+) T-cells, DCA induced apoptosis, and decreased the expression of glucose trasporter-1, hexokinase II, lactate dehydrogenase-A and phosphorylated pyruvate dehydrogenase, while it increased total pyruvate dehydrogenase. In addition, DCA increased the expression of transcription factor forkhead box P3, whereas it decreased the expression of T-box transcription factor TBX21, trans-acting T-cell-specific transcription factor GATA-3 and retinoic acid receptor related orphan receptor-gamma t. In conclusion, in alloreactive CD4(+) T-cells, DCA inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset. These characteristics render it a promising immunosuppressive agent in the field of transplantation.
引用
收藏
页码:3370 / 3376
页数:7
相关论文
共 50 条
  • [1] Metabolic Adaptation of Human CD4+ and CD8+ T-cells to T-cell Receptor-Mediated Stimulation
    Jones, Nicholas
    Cronin, James G.
    Dolton, Garry
    Panetti, Silvia
    Schauenburg, Andrea J.
    Galloway, Sarah A. E.
    Sewell, Andrew K.
    Cole, David K.
    Thornton, Catherine A.
    Francis, Nigel J.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] CD4+ T-cell subsets in intestinal inflammation
    Shale, Matthew
    Schiering, Chris
    Powrie, Fiona
    IMMUNOLOGICAL REVIEWS, 2013, 252 : 164 - 182
  • [3] CD4+ T-cell differentiation and function: Unifying glycolysis, fatty acid oxidation, polyamines NAD mitochondria
    Almeida, Luis
    Dhillon-LaBrooy, Ayesha
    Carriche, Guilhermina
    Berod, Luciana
    Sparwasser, Tim
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (01) : 16 - 32
  • [4] CD4+ T-cell subsets in autoimmune hepatitis: A review
    Chen, Haoran
    Han, Zhongyu
    Fan, Yiyue
    Chen, Liuyan
    Peng, Fang
    Cheng, Xuhua
    Wang, Yi
    Su, Junyan
    Li, Dongxuan
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (10)
  • [5] INDUCTION OF TOLERANCE IN FRESHLY ISOLATED ALLOREACTIVE CD4(+) T-CELLS BY ACTIVATED T-CELL STIMULATORS
    SATYARAJ, E
    RATH, S
    BAL, V
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) : 2457 - 2461
  • [6] Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus
    Comte, Denis
    Karampetsou, Maria P.
    Kis-Toth, Katalin
    Yoshida, Nobuya
    Bradley, Sean J.
    Mizui, Masayuki
    Kono, Michihito
    Solomon, Julie R.
    Kyttaris, Vasileios C.
    Tsokos, George C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (33) : 9321 - 9326
  • [7] Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype
    Maccario, Rita
    Podesta, Marina
    Moretta, Antonia
    Cometa, Angela
    Comoli, Patrizia
    Montagna, Daniela
    Daudt, Liane
    Ibatici, Adalberto
    Piaggio, Giovanna
    Pozzi, Sarah
    Frassoni, Francesco
    Locatelli, Franco
    HAEMATOLOGICA, 2005, 90 (04) : 516 - 525
  • [8] Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population
    Blanco, Belen
    Perez-Simon, Jose A.
    Sanchez-Abarca, Luis I.
    Caballero-Velazquez, Teresa
    Gutierrez-Cossio, Silvia
    Hernandez-Campo, Pilar
    Diez-Campelo, Maria
    Herrero-Sanchez, Carmen
    Rodriguez-Serrano, Concepcion
    Santamaria, Carlos
    Sanchez-Guijo, Fermin M.
    del Canizo, Consuelo
    San Miguel, Jesus F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (07): : 975 - 983
  • [9] A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties
    Ndhlovu, Lishomwa C.
    Leal, Fabio E.
    Eccles-James, Ijeoma G.
    Jha, Aashish R.
    Lanteri, Marion
    Norris, Philip J.
    Barbour, Jason D.
    Wachter, Douglas J.
    Andersson, Jan
    Tasken, Kjetil
    Torheim, Eirik A.
    Aandahl, Einar M.
    Kallas, Esper G.
    Nixon, Douglas F.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (01) : 134 - 141
  • [10] 1,25-Dihydroxyvitamin D3 suppresses CD4+ T-cell effector functionality by inhibition of glycolysis
    Bishop, Emma L.
    Gudgeon, Nancy H.
    Mackie, Gillian M.
    Chauss, Daniel
    Roberts, Jennie
    Tennant, Daniel A.
    Maslowski, Kendle M.
    Afzali, Behdad
    Hewison, Martin
    Dimeloe, Sarah
    IMMUNOLOGY, 2022, 166 (03) : 299 - 309